Bolt Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 137.72 K | $753.06 K | 0.00% | 7.18% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2026 | 94.57 K | $517.13 K | 0.00% | 4.93% |
| VIVO CAPITAL, LLC | 02/13/2026 | 72.41 K | $395.96 K | -58.87% | 3.77% |
| NAN FUNG GROUP HOLDINGS LTD | 02/13/2026 | 58.35 K | $319.04 K | 0.00% | 3.04% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 55.03 K | $300.88 K | 92.23% | 2.87% |
| 02/11/2026 | 38.00 K | $207.78 K | 100.00% | 1.98% | |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 02/17/2026 | 35.98 K | $196.72 K | 0.00% | 1.87% |
| PFIZER INC | 02/12/2026 | 31.31 K | $171.18 K | 0.00% | 1.63% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 02/06/2026 | 20.50 K | $112.09 K | 100.00% | 1.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 18.80 K | $103.06 K | 1.46% | 0.98% |
| SHAY CAPITAL LLC | 02/17/2026 | 15.27 K | $83.51 K | -4.30% | 0.80% |
| VANGUARD GROUP INC | 01/29/2026 | 10.18 K | $55.78 K | -70.26% | 0.53% |
| BLACKROCK, INC. | 02/12/2026 | 9.71 K | $53.10 K | 0.00% | 0.51% |
| MORGAN STANLEY | 02/13/2026 | 3.13 K | $17.10 K | 0.00% | 0.16% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 723 | $3.95 K | 179.15% | 0.04% |
| UBS GROUP AG | 01/29/2026 | 515 | $2.82 K | 17,066.67% | 0.03% |
| CITIGROUP INC | 02/13/2026 | 256 | $1.40 K | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 02/11/2026 | 42 | $230 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 31 | $169 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 10 | $55 | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 6 | $33 | 0.00% | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 01/12/2026 | 0 | $0 | -100.00% | 0.00% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SAMSARA BIOCAPITAL, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bolt Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Bolt Biotherapeutics Inc. The most heavily invested institutionals were:
Board of Trustees of The Leland Stanford Junior University: 35,977
PFIZER INC: 31,305
Lynx1 Capital Management LP: 30,800
VANGUARD FIDUCIARY TRUST CO: 3,095
UBS Group AG: 787
Vanguard Global Advisers, LLC: 24
31.39% of Bolt Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.49 M shares in the last 24 months. This purchase volume represents approximately $6.13 M in transactions.